348 related articles for article (PubMed ID: 26609932)
21. Dual-responsive mPEG-PLGA-PGlu hybrid-core nanoparticles with a high drug loading to reverse the multidrug resistance of breast cancer: an in vitro and in vivo evaluation.
Xu H; Yang D; Cai C; Gou J; Zhang Y; Wang L; Zhong H; Tang X
Acta Biomater; 2015 Apr; 16():156-68. PubMed ID: 25662165
[TBL] [Abstract][Full Text] [Related]
22. Tumor delivery of liposomal doxorubicin prepared with poly-L-glutamic acid as a drug-trapping agent.
Miatmoko A; Kawano K; Yoda H; Yonemochi E; Hattori Y
J Liposome Res; 2017 Jun; 27(2):99-107. PubMed ID: 26982164
[TBL] [Abstract][Full Text] [Related]
23. A comparative study of linear, Y-shaped and linear-dendritic methoxy poly(ethylene glycol)-block-polyamidoamine-block-poly(l-glutamic acid) block copolymers for doxorubicin delivery in vitro and in vivo.
Zhang Y; Xiao C; Ding J; Li M; Chen X; Tang Z; Zhuang X; Chen X
Acta Biomater; 2016 Aug; 40():243-253. PubMed ID: 27063495
[TBL] [Abstract][Full Text] [Related]
24. Hyaluronate tethered, "smart" multiwalled carbon nanotubes for tumor-targeted delivery of doxorubicin.
Datir SR; Das M; Singh RP; Jain S
Bioconjug Chem; 2012 Nov; 23(11):2201-13. PubMed ID: 23039830
[TBL] [Abstract][Full Text] [Related]
25. Development, characterization and cancer targeting potential of surface engineered carbon nanotubes.
Mehra NK; Jain NK
J Drug Target; 2013 Sep; 21(8):745-58. PubMed ID: 23822734
[TBL] [Abstract][Full Text] [Related]
26. Ligand-directed reduction-sensitive shell-sheddable biodegradable micelles actively deliver doxorubicin into the nuclei of target cancer cells.
Zhong Y; Yang W; Sun H; Cheng R; Meng F; Deng C; Zhong Z
Biomacromolecules; 2013 Oct; 14(10):3723-30. PubMed ID: 23998942
[TBL] [Abstract][Full Text] [Related]
27. Preparation of a camptothecin prodrug with glutathione-responsive disulfide linker for anticancer drug delivery.
Xu Z; Wang D; Xu S; Liu X; Zhang X; Zhang H
Chem Asian J; 2014 Jan; 9(1):199-205. PubMed ID: 24136878
[TBL] [Abstract][Full Text] [Related]
28. pH-sensitive degradable chimaeric polymersomes for the intracellular release of doxorubicin hydrochloride.
Du Y; Chen W; Zheng M; Meng F; Zhong Z
Biomaterials; 2012 Oct; 33(29):7291-9. PubMed ID: 22795540
[TBL] [Abstract][Full Text] [Related]
29. Drug resistance reversal activity of anticancer drug loaded solid lipid nanoparticles in multi-drug resistant cancer cells.
Miao J; Du YZ; Yuan H; Zhang XG; Hu FQ
Colloids Surf B Biointerfaces; 2013 Oct; 110():74-80. PubMed ID: 23711779
[TBL] [Abstract][Full Text] [Related]
30. Fine tuning micellar core-forming block of poly(ethylene glycol)-block-poly(ε-caprolactone) amphiphilic copolymers based on chemical modification for the solubilization and delivery of doxorubicin.
Yan J; Ye Z; Chen M; Liu Z; Xiao Y; Zhang Y; Zhou Y; Tan W; Lang M
Biomacromolecules; 2011 Jul; 12(7):2562-72. PubMed ID: 21598958
[TBL] [Abstract][Full Text] [Related]
31. Multifunctional PEG-b-polypeptide-decorated gold nanorod for targeted combined chemo-photothermal therapy of breast cancer.
Hou G; Qian J; Xu W; Sun T; Wang J; Wang Y; Suo A
Colloids Surf B Biointerfaces; 2019 Sep; 181():602-611. PubMed ID: 31202131
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of doxorubicin-loaded 3-helix micelles as nanocarriers.
Dube N; Shu JY; Dong H; Seo JW; Ingham E; Kheirolomoom A; Chen PY; Forsayeth J; Bankiewicz K; Ferrara KW; Xu T
Biomacromolecules; 2013 Oct; 14(10):3697-705. PubMed ID: 24050265
[TBL] [Abstract][Full Text] [Related]
33. Tailored design of multifunctional and programmable pH-responsive self-assembling polypeptides as drug delivery nanocarrier for cancer therapy.
Wang TW; Yeh CW; Kuan CH; Wang LW; Chen LH; Wu HC; Sun JS
Acta Biomater; 2017 Aug; 58():54-66. PubMed ID: 28606810
[TBL] [Abstract][Full Text] [Related]
34. Folate/N-acetyl glucosamine conjugated mesoporous silica nanoparticles for targeting breast cancer cells: A comparative study.
Kumar P; Tambe P; Paknikar KM; Gajbhiye V
Colloids Surf B Biointerfaces; 2017 Aug; 156():203-212. PubMed ID: 28531877
[TBL] [Abstract][Full Text] [Related]
35. Treatment of metastatic breast cancer by combination of chemotherapy and photothermal ablation using doxorubicin-loaded DNA wrapped gold nanorods.
Wang D; Xu Z; Yu H; Chen X; Feng B; Cui Z; Lin B; Yin Q; Zhang Z; Chen C; Wang J; Zhang W; Li Y
Biomaterials; 2014 Sep; 35(29):8374-84. PubMed ID: 24996756
[TBL] [Abstract][Full Text] [Related]
36. Self-assembling doxorubicin-tocopherol succinate prodrug as a new drug delivery system: synthesis, characterization, and in vitro and in vivo anticancer activity.
Duhem N; Danhier F; Pourcelle V; Schumers JM; Bertrand O; Leduff CS; Hoeppener S; Schubert US; Gohy JF; Marchand-Brynaert J; Préat V
Bioconjug Chem; 2014 Jan; 25(1):72-81. PubMed ID: 24328289
[TBL] [Abstract][Full Text] [Related]
37. Magnetic targeted drug delivery carriers encapsulated with pH-sensitive polymer: synthesis, characterization and in vitro doxorubicin release studies.
Wu J; Shen Y; Jiang W; Jiang W; Shen Y
J Biomater Sci Polym Ed; 2016 Sep; 27(13):1303-16. PubMed ID: 27252073
[TBL] [Abstract][Full Text] [Related]
38. Charge-conversional and reduction-sensitive poly(vinyl alcohol) nanogels for enhanced cell uptake and efficient intracellular doxorubicin release.
Chen W; Achazi K; Schade B; Haag R
J Control Release; 2015 May; 205():15-24. PubMed ID: 25445693
[TBL] [Abstract][Full Text] [Related]
39. pH-sensitive Laponite(®)/doxorubicin/alginate nanohybrids with improved anticancer efficacy.
Gonçalves M; Figueira P; Maciel D; Rodrigues J; Qu X; Liu C; Tomás H; Li Y
Acta Biomater; 2014 Jan; 10(1):300-7. PubMed ID: 24075886
[TBL] [Abstract][Full Text] [Related]
40. Pulmonary Codelivery of Doxorubicin and siRNA by pH-Sensitive Nanoparticles for Therapy of Metastatic Lung Cancer.
Xu C; Wang P; Zhang J; Tian H; Park K; Chen X
Small; 2015 Sep; 11(34):4321-33. PubMed ID: 26136261
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
